SCHEMBL17866090

SCHEMBL17866090

CCCC(=O)OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC2A1 P11166 1/20 0.47
▸ TLR4 O00206 1/20 0.45
▸ PTGS1 P23219 2/20 0.42
▸ PTGS2 P35354 2/20 0.42
▸ PYGB P11216 3/20 0.42
▸ PRKD3 O94806 1/20 0.42
▸ PRKCG P05129 1/20 0.42
▸ PRKCB P05771 1/20 0.42
▸ PRKCA P17252 1/20 0.42
▸ PRKCH P24723 1/20 0.42
▸ PRKCI P41743 1/20 0.42
▸ PRKCE Q02156 1/20 0.42
▸ PRKCQ Q04759 1/20 0.42
▸ PRKCZ Q05513 1/20 0.42
▸ PRKCD Q05655 1/20 0.42
▸ PRKD1 Q15139 1/20 0.42
▸ MAPT P10636 1/20 0.40
▸ NLRP3 Q96P20 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.36
▸ CA2 P00918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13561242 0.90 SLC2A1 (0.51) SLC2A1TLR4PTGS1PTGS2PRKD3
SCHEMBL10325671 0.90 SLC2A1 (0.51) SLC2A1TLR4PTGS1PTGS2PRKD3
SCHEMBL10325673 0.90 SLC2A1 (0.51) SLC2A1TLR4PTGS1PTGS2PRKD3
SCHEMBL9228629 0.89 TLR4 (0.51) SLC2A1TLR4PTGS1PTGS2AKT1
SCHEMBL17866084 0.89 TLR4 (0.51) SLC2A1TLR4PTGS1PTGS2AKT1
SCHEMBL17318218 0.89 SLC2A1 (0.49) SLC2A1TLR4PTGS1PTGS2PRKD3
SCHEMBL12427213 0.88 TLR4 (0.53) SLC2A1TLR4PTGS1PTGS2AKT1
SCHEMBL9231092 0.88 TLR4 (0.53) SLC2A1TLR4PTGS1PTGS2AKT1
SCHEMBL21662370 0.88 TLR4 (0.53) SLC2A1TLR4PTGS1PTGS2AKT1
SCHEMBL9229342 0.88 TLR4 (0.53) SLC2A1TLR4PTGS1PTGS2AKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1782828-B1 PROGRESSION INHIBITOR FOR DISEASE ATTRIBUTED TO ABNORMAL ACCUMULATION OF LIVER FAT KISSEI PHARMACEUTICAL (JP) 2016-06-29 — — EP claimed
Send feedback